AstraZeneca is leaving no stone unturned in its effort to make baxdrostat the first aldosterone synthase inhibitor (ASI) to get approval for hard-to-treat hypertension. The FDA has now started a ...
Move to modernise: Widiyanto presenting the soon-to-be-launched ‘All Indonesia’ app during a media briefing at the consulate. JOHOR BARU: Starting Monday, all foreign visitors, including Malaysians, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results